Report Detail

Pharma & Healthcare Global Dolutegravir Market Insights, Forecast to 2025

  • RnM3447346
  • |
  • 22 May, 2019
  • |
  • Global
  • |
  • 114 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Dolutegravir market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dolutegravir market based on company, product type, end user and key regions.

This report studies the global market size of Dolutegravir in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dolutegravir in these regions.
This research report categorizes the global Dolutegravir market by top players/brands, region, type and end user. This report also studies the global Dolutegravir market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
ViiV Healthcare (GSK)
Shanghai Desano Pharmaceuticals
Mylan
Aurobindo Pharma
LAURUS Labs
Adcock Ingram Limited

Dolutegravir market size by Type
10mg Tablets
50mg Tablets
Dolutegravir market size by Applications
Prevent HIV Infection Following Potential Exposure
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Dolutegravir market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dolutegravir market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dolutegravir companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dolutegravir submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Dolutegravir are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dolutegravir market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Dolutegravir Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Dolutegravir Market Size Growth Rate by Type
      • 1.4.2 10mg Tablets
      • 1.4.3 50mg Tablets
    • 1.5 Market by Application
      • 1.5.1 Global Dolutegravir Market Size Growth Rate by Application
      • 1.5.2 Prevent HIV Infection Following Potential Exposure
      • 1.5.3 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Dolutegravir Market Size
      • 2.1.1 Global Dolutegravir Revenue 2014-2025
      • 2.1.2 Global Dolutegravir Sales 2014-2025
    • 2.2 Dolutegravir Growth Rate by Regions
      • 2.2.1 Global Dolutegravir Sales by Regions
      • 2.2.2 Global Dolutegravir Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Dolutegravir Sales by Manufacturers
      • 3.1.1 Dolutegravir Sales by Manufacturers
      • 3.1.2 Dolutegravir Sales Market Share by Manufacturers
    • 3.2 Dolutegravir Revenue by Manufacturers
      • 3.2.1 Dolutegravir Revenue by Manufacturers (2014-2019)
      • 3.2.2 Dolutegravir Revenue Share by Manufacturers (2014-2019)
    • 3.3 Dolutegravir Price by Manufacturers
    • 3.4 Dolutegravir Manufacturing Base Distribution, Product Types
      • 3.4.1 Dolutegravir Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Dolutegravir Product Type
      • 3.4.3 Date of International Manufacturers Enter into Dolutegravir Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Dolutegravir Sales by Type
    • 4.2 Global Dolutegravir Revenue by Type
    • 4.3 Dolutegravir Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Dolutegravir Breakdown Data by Application

    6 North America

    • 6.1 North America Dolutegravir by Country
      • 6.1.1 North America Dolutegravir Sales by Country
      • 6.1.2 North America Dolutegravir Revenue by Country
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Dolutegravir by Type
    • 6.3 North America Dolutegravir by Application

    7 Europe

    • 7.1 Europe Dolutegravir by Country
      • 7.1.1 Europe Dolutegravir Sales by Country
      • 7.1.2 Europe Dolutegravir Revenue by Country
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Dolutegravir by Type
    • 7.3 Europe Dolutegravir by Application

    8 Asia Pacific

    • 8.1 Asia Pacific Dolutegravir by Country
      • 8.1.1 Asia Pacific Dolutegravir Sales by Country
      • 8.1.2 Asia Pacific Dolutegravir Revenue by Country
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Dolutegravir by Type
    • 8.3 Asia Pacific Dolutegravir by Application

    9 Central & South America

    • 9.1 Central & South America Dolutegravir by Country
      • 9.1.1 Central & South America Dolutegravir Sales by Country
      • 9.1.2 Central & South America Dolutegravir Revenue by Country
      • 9.1.3 Brazil
      • 9.1.4 Argentina
    • 9.2 Central & South America Dolutegravir by Type
    • 9.3 Central & South America Dolutegravir by Application

    10 Middle East and Africa

    • 10.1 Middle East and Africa Dolutegravir by Country
      • 10.1.1 Middle East and Africa Dolutegravir Sales by Country
      • 10.1.2 Middle East and Africa Dolutegravir Revenue by Country
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Dolutegravir by Type
    • 10.3 Middle East and Africa Dolutegravir by Application

    11 Company Profiles

    • 11.1 ViiV Healthcare (GSK)
      • 11.1.1 ViiV Healthcare (GSK) Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 ViiV Healthcare (GSK) Dolutegravir Products Offered
      • 11.1.5 ViiV Healthcare (GSK) Recent Development
    • 11.2 Shanghai Desano Pharmaceuticals
      • 11.2.1 Shanghai Desano Pharmaceuticals Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Shanghai Desano Pharmaceuticals Dolutegravir Products Offered
      • 11.2.5 Shanghai Desano Pharmaceuticals Recent Development
    • 11.3 Mylan
      • 11.3.1 Mylan Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Mylan Dolutegravir Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Mylan Dolutegravir Products Offered
      • 11.3.5 Mylan Recent Development
    • 11.4 Aurobindo Pharma
      • 11.4.1 Aurobindo Pharma Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Aurobindo Pharma Dolutegravir Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Aurobindo Pharma Dolutegravir Products Offered
      • 11.4.5 Aurobindo Pharma Recent Development
    • 11.5 LAURUS Labs
      • 11.5.1 LAURUS Labs Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 LAURUS Labs Dolutegravir Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 LAURUS Labs Dolutegravir Products Offered
      • 11.5.5 LAURUS Labs Recent Development
    • 11.6 Adcock Ingram Limited
      • 11.6.1 Adcock Ingram Limited Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Adcock Ingram Limited Dolutegravir Products Offered
      • 11.6.5 Adcock Ingram Limited Recent Development

    12 Future Forecast

    • 12.1 Dolutegravir Market Forecast by Regions
      • 12.1.1 Global Dolutegravir Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Dolutegravir Revenue Forecast by Regions 2019-2025
    • 12.2 Dolutegravir Market Forecast by Type
      • 12.2.1 Global Dolutegravir Sales Forecast by Type 2019-2025
      • 12.2.2 Global Dolutegravir Revenue Forecast by Type 2019-2025
    • 12.3 Dolutegravir Market Forecast by Application
    • 12.4 North America Dolutegravir Forecast
    • 12.5 Europe Dolutegravir Forecast
    • 12.6 Asia Pacific Dolutegravir Forecast
    • 12.7 Central & South America Dolutegravir Forecast
    • 12.8 Middle East and Africa Dolutegravir Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Dolutegravir Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Dolutegravir . Industry analysis & Market Report on Dolutegravir is a syndicated market report, published as Global Dolutegravir Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dolutegravir market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,073.20
      4,609.80
      6,146.40
      3,588.00
      5,382.00
      7,176.00
      606,918.00
      910,377.00
      1,213,836.00
      325,182.00
      487,773.00
      650,364.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report